🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Preoperative Stereotactic Radiotherapy for Treatment of Spinal Metastases

RecruitingNAAges 18 Years - anyAllUniversity Medical Center Goettingen
NCT07135817 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The goal of this interventional clinical trial is to evaluate the efficacy and safety of preoperative hypofractionated Stereotactic Body Radiotherapy (SBRT) in the treatment of patients undergoing surgery for spinal metastases. The main questions this study aims to answer are: * Does preoperative SBRT result in local tumor control at the involved spinal segments as assessed by MRI/CT scan at 3 and 6 months postoperatively? * What are the postoperative outcomes in terms of pain intensity, functional status and quality of life? Participants will receive hypofractionated SBRT to spinal metastases shortly before surgical intervention. Participants will undergo preoperative and follow-up assessments, including: * MRI and CT scans before and after surgery and at 3 and 6 months after surgery to measure tumor size * Pain questionnaires where patients rate their current pain, worst pain, and

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Indication for surgical treatment of a spinal tumor * Age: older or 18 years * Estimated survival \> 6 months * The patient is able to understand the nature, significance and scope of the clinical study in the context of patient information and to base the decision to participate in the study on this. Exclusion Criteria: * Age: \< 18 years * Motor deficit or loss of bladder and bowel control that urges an emergency surgical decompression * Tumor extent does not allow hypofractioned SBRT (1-3 fractions)
💊

What it tests

  • Preoperative Stereotactic Body Radiotherapy (SBRT)
  • Spinal Surgery for Decompression and/or Stabilization
📍

Where

1 site
University Medical Center Goettingen
Göttingen, Germany
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy